Get the full Violet Therapeutics company profile
Access contacts, investors, buying signals & more
Mapping cell-to-cell communication to unlock new drug targets for CNS diseases, Violet Therapeutics has raised $4.8M in seed capital.
The pre-clinical stage company, co-founded in 2021 by Mass General Brigham Ventures and scientists from Brigham & Women’s Hospital, is leveraging its first-in-class platforms to identify, map, and mine cell-to-cell communication at scale for its drug discovery programs focused on central nervous system diseases.
Modu Tech
Modu Tech offers general contractors and individual owners alike with turnkey carpentry products by providing a one stop shop for framing labor, building materials and trusses. Since 1986, Modu Tech has specialized in multi-family apartments operating with our-in house partner Stark Truss Baltimore. We offer a complete and vertically integrated manufacturing and installation process. Our close relationship with the National Framers Council offers constant updates to changing market trends and other new industry-based information that keeps Modu Tech connected with other framers throughout the country while also providing an opportunity for us to share our knowledge back to the community through Webinars and regular meetings.
$4.4M Pre-seed
today
DIMENSION
A first-of-its-kind fund partnering with founders at the interface of technology and life sciences to transform the trajectory of life on earth
$1.6M Seed
today
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | DIMENSION United States | Seed | $1.6M | today |
| 2 |  Dimension Studios United States | Seed | $1.6M | today |
| $7.2B |
| 1y ago |
| 3 |  Illumina United States | Unknown | $7.1B | 1y ago |
| 4 |  GRAIL United States | Unknown | $7.1B | 1y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 7mo ago |
| 3 |
 Demand AI United States |
| Seed |
| $6.3M |
| today |
| 4 |  Beta Bugs Limited United Kingdom | Seed | $1.1M | today |
| 5 |  AGent Energy United States | Seed | $11.0M | today |
Trusted by 200+ sales teams
See who invested in Violet Therapeutics and reach their contacts directly.
Start free trialUnlock 3 more key decision-makers at Violet Therapeutics with verified emails and LinkedIn.
Start free trial
Alcolase
Recently received
Anomaly
Recently received
Mersey and West Lancashire Teaching Hospitals NHS Trust
Recently received
